It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
3D genome alternations can dysregulate gene expression by rewiring enhancer-promoter interactions and lead to diseases. We report integrated analyses of 3D genome alterations and differential gene expressions in 18 newly diagnosed T-lineage acute lymphoblastic leukemia (T-ALL) patients and 4 healthy controls. 3D genome organizations at the levels of compartment, topologically associated domains and loop could hierarchically classify different subtypes of T-ALL according to T cell differentiation trajectory, similar to gene expressions-based classification. Thirty-four previously unrecognized translocations and 44 translocation-mediated neo-loops are mapped by Hi-C analysis. We find that neo-loops formed in the non-coding region of the genome could potentially regulate ectopic expressions of TLX3, TAL2 and HOXA transcription factors via enhancer hijacking. Importantly, both translocation-mediated neo-loops and NUP98-related fusions are associated with HOXA13 ectopic expressions. Patients with HOXA11-A13 expressions, but not other genes in the HOXA cluster, have immature immunophenotype and poor outcomes. Here, we highlight the potentially important roles of 3D genome alterations in the etiology and prognosis of T-ALL.
The non-coding genome of T-ALL has not been extensively studied. Here, the authors conduct RNA-seq, ATAC-seq and Hi-C seq analyses and find that T-ALL associated neo-loops may regulate key transcription factors including HOXA13; the aberrant expression of which is associated with poor prognosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Peking University, The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); Peking-Tsinghua Center for Life Sciences, Beijing, China (GRID:grid.452723.5) (ISNI:0000 0004 7887 9190)
2 Tsinghua University, MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, Bioinformatics Division, BNRist, Department of Automation, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178); Center for Stem Cell Biology and Regenerative Medicine, MOE Key Laboratory of Bioinformatics, Tsinghua University, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178); Tsinghua-Peking Center for Life Sciences, Beijing, China (GRID:grid.452723.5) (ISNI:0000 0004 7887 9190)
3 Peking University, The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); Peking-Tsinghua Center for Life Sciences, Beijing, China (GRID:grid.452723.5) (ISNI:0000 0004 7887 9190); Wuhan University of Science and Technology, Institute of Biology and Medicine, College of Life and Health Sciences, Hubei, China (GRID:grid.412787.f) (ISNI:0000 0000 9868 173X)
4 Tsinghua University, MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, Bioinformatics Division, BNRist, Department of Automation, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178); Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Biochemistry and Molecular Biology, The State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, School of Basic Medicine, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
5 Tsinghua University, MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, Bioinformatics Division, BNRist, Department of Automation, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178); Tsinghua University, School of Medicine, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178)
6 National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
7 Peking University People’s Hospital, Department of Pediatrics, Beijing, China (GRID:grid.411634.5) (ISNI:0000 0004 0632 4559)
8 Peking-Tsinghua Center for Life Sciences, Beijing, China (GRID:grid.452723.5) (ISNI:0000 0004 7887 9190); National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
9 Tsinghua University, MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, Bioinformatics Division, BNRist, Department of Automation, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178); Tsinghua University, School of Medicine, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178); The University of Texas, Department of Biological Sciences, Center for Systems Biology, Richardson, USA (GRID:grid.267323.1) (ISNI:0000 0001 2151 7939)
10 Peking University, The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); Peking-Tsinghua Center for Life Sciences, Beijing, China (GRID:grid.452723.5) (ISNI:0000 0004 7887 9190); National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)